Several approved drugs, such as copyright and Semaglutide, are part of the incretin mimetic category . Mainly, these therapies are designed to mimicking the body's own chemicals that impact glucose https://adreaxdhu501140.wikiusnews.com/2321290/semaglutide_and_glp_1_receptor_agonists_learning_about_the_treatments